VI‐RADS for bladder cancer: Current applications and future developments
V Panebianco, M Pecoraro… - Journal of Magnetic …, 2022 - Wiley Online Library
Bladder cancer (BCa) is among the ten most frequent cancers globally. It is the tumor with
the highest lifetime treatment‐associated costs, and among the tumors with the heaviest …
the highest lifetime treatment‐associated costs, and among the tumors with the heaviest …
Treatment outcomes of high-risk non-muscle invasive bladder cancer (HR-NMIBC) in real-world evidence (RWE) studies: systematic literature review (SLR)
MG Musat, CS Kwon, E Masters, S Sikirica… - ClinicoEconomics …, 2022 - Taylor & Francis
Background To date, there has been limited synthesis of RWE studies in high-risk non-
muscle invasive bladder cancer (HR-NMIBC). The objective of this research was to conduct …
muscle invasive bladder cancer (HR-NMIBC). The objective of this research was to conduct …
[HTML][HTML] Impact of the COVID-19 Pandemic on the Urologist's clinical practice in Brazil: a management guideline proposal for low-and middle-income countries during …
A Carneiro, ML Wroclawski, B Nahar, A Soares… - International braz j …, 2020 - SciELO Brasil
This letter to the Editor aims to provide suggestions and recommendations for the
management of urological conditions in times of COVID-19 crisis in Brazil and other low-and …
management of urological conditions in times of COVID-19 crisis in Brazil and other low-and …
[HTML][HTML] Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods
E Alchera, M Monieri, M Maturi, I Locatelli, E Locatelli… - Photoacoustics, 2022 - Elsevier
Detection and removal of bladder cancer lesions at an early stage is crucial for preventing
tumor relapse and progression. This study aimed to develop a new technological platform …
tumor relapse and progression. This study aimed to develop a new technological platform …
A simple and robust nanosystem for photoacoustic imaging of bladder cancer based on α5β1-targeted gold nanorods
Background Early detection and removal of bladder cancer in patients is crucial to prevent
tumor recurrence and progression. Because current imaging techniques may fail to detect …
tumor recurrence and progression. Because current imaging techniques may fail to detect …
Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics
A Ślusarczyk, P Zapała, Ł Zapała, T Piecha… - … Urology and Nephrology, 2019 - Springer
Abstract Bacillus Calmette–Guerin (BCG) instillations are considered as a gold standard of
therapy in high-and intermediate-risk non-muscle-invasive bladder cancer (NMIBC) …
therapy in high-and intermediate-risk non-muscle-invasive bladder cancer (NMIBC) …
Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS
TI Noh, JS Shim, SG Kang, DJ Sung, J Cheon… - Scientific Reports, 2022 - nature.com
This study aimed to compare the diagnostic validity of biparametric magnetic resonance
imaging (bpMRI) with that of multiparametric MRI (mpMRI) based on the Vesicle Imaging …
imaging (bpMRI) with that of multiparametric MRI (mpMRI) based on the Vesicle Imaging …
Gold nanorod–assisted theranostic solution for nonvisible residual disease in bladder cancer
P Armanetti, I Locatelli, C Venegoni, E Alchera… - Proceedings of the …, 2024 - pnas.org
Residual nonvisible bladder cancer after proper treatment caused by technological and
therapeutic limitations is responsible for tumor relapse and progression. This study aimed to …
therapeutic limitations is responsible for tumor relapse and progression. This study aimed to …
Does repeat transurethral resection of bladder tumor influence the diagnosis and prognosis of T1 bladder cancer? A systematic review and meta-analysis
L Lin, X Guo, Y Ma, J Zhu, X Li - European Journal of Surgical Oncology, 2023 - Elsevier
Background To reduce recurrence or progression of tumor, NCCN guidelines recommend
repeat transurethral resection of bladder tumors (reTURB) for non-muscle-invasive bladder …
repeat transurethral resection of bladder tumors (reTURB) for non-muscle-invasive bladder …
[HTML][HTML] Identification of potential prognostic factors for absence of residual disease in the second resection of T1 bladder cancer
AK Czech, K Gronostaj, J Frydrych… - … European Journal of …, 2019 - ncbi.nlm.nih.gov
Results Among the 139 patients who met the inclusion criteria, 96 (69.1%) had no residual
disease (T0) and 43 (30.9%) had residual disease in the second resection (including muscle …
disease (T0) and 43 (30.9%) had residual disease in the second resection (including muscle …